Skip to main content

(Approval lapsed) Metronidazole 200mg/5mL oral suspension (Rosemont)

Section 19A approved medicine
(Approval lapsed) Metronidazole 200mg/5mL oral suspension (Rosemont)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
0422 429 648
Approved until
Medicines in short supply/unavailable
FLAGYL S benzoyl metronidazole 64 mg/mL suspension oral liquid bottle - ARTG 27501

Anaerobic Infections

Treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly Bacteroides fragilis and other species of bacteroides, and other species such as fusobacteria, eubacteria, clostridia and anaerobic streptococci. Metronidazole has been used successfully in septicaemia; bacteraemia; brain abscess; necrotising pneumonia; osteomyelitis; puerperal sepsis; pelvic abscess; pelvic cellulitis; postoperative wound infections.


  1. Because of the slow absorption and delayed peak plasma level, metronidazole suspension is not recommended for use in the acute situation.
  2. Metronidazole is inactive against aerobic and facultative anaerobic bacteria.

Other Indications

Oral treatment of urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male, and for the treatment of bacterial vaginosis. The male consort of females suffering from urogenital trichomoniasis should be treated concurrently; all forms of amoebiasis (intestinal and extraintestinal disease and that of symptomless cyst passers); giardiasis; acute ulcerative gingivitis.

Picture of Metronidazole 200mg/5mL oral suspension (Rosemont)

Help us improve the Therapeutic Goods Administration site